1 |
Details of the person discharging managerial responsibilities / person closely associated |
a) |
Name |
Mohammed 'Ali' Al-Husry |
2 |
Reason for the notification |
a) |
Position/status |
Non-executive Director/ PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Acquisition by Darhold Limited of 10,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.01% through DKYB Limited, a vehicle owned by his family. |
c) |
Price(s) and volume(s) |
Price(s): £16.74 Volume(s): 50,000 Price(s): £16.82 Volume(s): 100,000 |
d) |
Aggregated information |
Aggregated volume: 150,000 Price: £16.79 |
e) |
Date of the transaction |
5 December and 6 December 2016 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |